发明授权
US08653076B2 Oxo-substituted imidazo[1,2B]pyridazines, their preparation and use as pharmaceuticals
失效
氧代取代的咪唑并[1,2B]哒嗪，其制备和用作药物
![Oxo-substituted imidazo[1,2B]pyridazines, their preparation and use as pharmaceuticals](/docs/US/2014-02-18/US08653076B2/abs.jpg.600x600.jpg)
- 专利标题： Oxo-substituted imidazo[1,2B]pyridazines, their preparation and use as pharmaceuticals
- 专利标题（中）： 氧代取代的咪唑并[1,2B]哒嗪，其制备和用作药物
-
申请号： US11765638申请日： 2007-06-20
-
公开(公告)号： US08653076B2公开(公告)日： 2014-02-18
- 发明人: Olaf Prien , Knut Eis , Benjamin Bader , Judith Guenther , Arne Von Bonin
- 申请人： Olaf Prien , Knut Eis , Benjamin Bader , Judith Guenther , Arne Von Bonin
- 申请人地址： DE Moneheim
- 专利权人： Bayer Intellectual Property GmbH
- 当前专利权人： Bayer Intellectual Property GmbH
- 当前专利权人地址： DE Moneheim
- 优先权： DE10200602944 20060621
- 主分类号： C07D487/04
- IPC分类号： C07D487/04 ; A61K31/5025 ; A61P29/00 ; A61P3/10 ; A61P11/06
![Oxo-substituted imidazo[1,2B]pyridazines, their preparation and use as pharmaceuticals](/abs-image/US/2014/02/18/US08653076B2/abs.jpg.150x150.jpg)
摘要：
The invention relates to novel inhibitors of kinases of the general formula (I): in which Q and R1 are defined in the claims, method for preparing such inhibitors, intermediates for preparing such inhibitors and uses of such inhibitors.